No Record Found
Sector
PharmaceuticalsOpen
₹101.79Prev. Close
₹100.19Turnover(Lac.)
₹15.53Day's High
₹102.66Day's Low
₹10052 Week's High
₹31752 Week's Low
₹98Book Value
₹29.55Face Value
₹1Mkt Cap (₹ Cr.)
922.61P/E
0EPS
0Divi. Yield
0.5No Record Found
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 9.2 | 9.2 | 9.2 | 9.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 311.08 | 292.07 | 272.62 | 234.28 |
Net Worth | 320.28 | 301.27 | 281.82 | 243.48 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 230.66 | 201.58 | 209.5 | 216.65 |
yoy growth (%) | 14.42 | -3.77 | -3.3 | 6.78 |
Raw materials | -78.2 | -63.18 | -71.66 | -70.7 |
As % of sales | 33.9 | 31.34 | 34.2 | 32.63 |
Employee costs | -39.98 | -44.27 | -44.61 | -39.99 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 32.24 | 18 | 9.39 | 16.39 |
Depreciation | -8.54 | -8.26 | -7.4 | -7.47 |
Tax paid | -5.62 | -2.09 | -0.1 | -1.6 |
Working capital | 7.89 | 27.14 | 18.07 | 18.93 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 14.42 | -3.77 | -3.3 | 6.78 |
Op profit growth | 39.8 | 39.17 | -21.85 | 4.4 |
EBIT growth | 45.57 | 45.24 | -24.69 | 5.8 |
Net profit growth | 67.29 | 71.19 | -37.16 | -1.8 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 405.51 | 381.76 | 354.32 | 394.61 | 230.67 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 405.51 | 381.76 | 354.32 | 394.61 | 230.67 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 10.59 | 23.56 | 25.12 | 17.88 | 13.1 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,582.3 | 76.22 | 3,79,658.77 | 753.53 | 1.01 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,133.5 | 69.73 | 1,62,886.21 | 557 | 0.49 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,577.8 | 24.67 | 1,27,435.32 | 1,303.13 | 1.01 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,599.3 | 61.23 | 1,21,713.05 | 551 | 0.17 | 2,567 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,568.9 | 58.53 | 1,05,917.96 | 412.76 | 0 | 2,541.36 | 354.69 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Exec. Director
Dinesh S Patel
ED / MD / CEO / Promoter
Sachin D Patel
Non-Exec & Non-Independent Dir
Reena S Patel
Non-Exec & Non-Independent Dir
Rajneesh Anand
Non-Exec & Non-Independent Dir
Adam Demeter
Independent Non Exe. Director
Manjul Sandhu
Independent Non Exe. Director
Bhaskar Vemban Iyer
Independent Non Exe. Director
Shishir Dalal
Independent Non Exe. Director
Nikunt Raval
Independent Director
Neha Thakore
Plot No 69 A GIDC Indl Estate,
Vapi,
Gujarat - 396195
Tel: 91-260-2421675
Website: http://www.themismedicare.com
Email: sangameshwar.iyer@themismedicare.com; cfoassist@th
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Themis Medicare Limited was formerly incorporated as Themis Chemicals Limited in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibh...
Read More
Reports by Themis Medicare Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.